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Abstract
Neuronal glucose transporter (GLUT) isoform 3 deficiency in null heterozygous mice led to 
abnormal spatial learning and working memory but normal acquisition and retrieval during 
contextual conditioning, abnormal cognitive flexibility with intact gross motor ability, 
electroencephalographic seizures, perturbed social behavior with reduced vocalization and 
stereotypies at low frequency. This phenotypic expression is unique as it combines the 
neurobehavioral with the epileptiform characteristics of autism spectrum disorders. This clinical 
presentation occurred despite metabolic adaptations consisting of an increase in microvascular/
glial GLUT1, neuronal GLUT8 and monocarboxylate transporter (MCT) isoform 2 
concentrations, with minimal to no change in brain glucose uptake but an increase in lactate 
uptake. Neuron-specific glucose deficiency has a negative impact on neurodevelopment 
interfering with functional competence. This is the first description of GLUT3 deficiency that 
forms a possible novel genetic mechanism for pervasive developmental disorders, such as the 
neuropsychiatric autism spectrum disorders, requiring further investigation in humans.
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Autism spectrum disorders (ASD) constitute a chronic debilitating neuropsychiatric 
condition diagnosed in childhood and with long term consequences. At present there are no 
specific treatments targeted at complete reversal of symptoms towards achieving functional 
competence. ASDs are part of pervasive developmental disorders that present with abnormal 
social interactions, aberrant verbal and non-verbal communication skills, learning 
disabilities, mild mental retardation, stereotypic behaviors with a subset of individuals 
developing electroencephalographic seizure activity. These disorders are diagnosed in 
infancy/childhood and seen in adolescence and adults (1). While a genetic basis for this 
disorder has been put forth the underlying definitive cause has remained elusive. More 
recently proposed gene(s) for autism have been located on chromosome 16 which are 
responsible for only 1% of the clinical disorder (1). Mounting evidence has supported 
environmental factors such as perinatal events and nutrition to play an etiological role in 
ASD (2, 3). Positron emission tomography of human brain has revealed decreased brain 
glucose uptake in ASD (4, 5, 6). Abnormal neuronal energy metabolism due to aberrant fuel 
supply, particularly glucose, during development may form the common denominator for 
these disorders.
Glucose forms the essential substrate that fuels neuronal oxidative metabolism. This 
substrate is transported across the blood-brain barrier and into neurons and glia via a family 
of structurally related membrane-spanning glycoproteins, termed the facilitative glucose 
transporters (7). Of the multiple isoforms cloned to date, GLUT1 is the predominant isoform 
expressed in the blood-brain barrier and glial cells (8), and GLUT3 is the neuronal isoform 
(9). While other isoforms are expressed to a lesser extent in neurons, such as GLUT8 and 
GLUT4 (10, 11), GLUT3 is the predominant neuronal isoform that fuels ATP generation 
and thereby the energy metabolism (12). We therefore hypothesized that GLUT3 deficiency 
will alter brain metabolism and perturb neurobehavior through development resulting in a 
phenotype that may resemble clinical ASD. To test this hypothesis we created a glut3 null 
mouse and observed embryonic lethality in homozygotes (13) while the heterozygotes had 
no malformations and survived into adulthood. We examined these glut3 heterozygous null 
(glut3+/−) mice through development for neurobehavioral changes and observed features 
relevant to ASD.
Materials and Methods
Glut3 null mouse lines
The mouse glut3 (Slc2a3) knockout targeting construct was created by isolating and 
characterizing the entire glut3 gene in a P1 clone (Genome Systems, St. Louis, MO) and 
using the pKO Scrambler NTK 1903 vector (Stratagene, La Jolla, CA) to delete a 3.5 kb 
fragment consisting of exons 7, 8, 9 and the coding region of 10. (13). Glut3 (Slc2a3) 
knockout mouse lines were generated and back crossed to achieve a homogeneous C57/BL6 
strain background, genotyped as described previously by us (13), housed in 12-h light and 
12-h dark cycle and maintained in approved mouse housing areas. All mouse studies were 
approved by Animal Research Committee of the University of California, Los Angeles in 
accordance with guidelines set by the National Institutes of Health.
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Glucose transporter protein studies
Whole brains at different postnatal stages (PN1, 7, 14, 21 and 60 days) were subjected to 
Western blot analysis as described previously (10, 11). The primary antibodies consisted of 
rabbit anti-mouse GLUT1 IgG (1:2000 dilution) (14), anti-mouse GLUT3 IgG (1:2000 
dilution) (15), rabbit anti-mouse GLUT8 IgG, rabbit anti-rat MCT1 (1:200 dilution) and 
anti-rat MCT2 antibody (1:400 dilution) (the latter three antibodies were obtained from 
Alpha Diagnostic International, San Antonio, TX). The internal control was detected using a 
monoclonal anti-human vinculin antibody (1:4000 dilution) (Sigma Chemical Co., St. Louis, 
MO). The protein bands were quantified by densitometry and the arbitrary units expressed 
as a ratio to vinculin. The developmental expression of each protein was presented as a 
percent of PN60 WT value normalized to 100%.
Brain 2-deoxyglucose uptake
Cerebral 14C-2-deoxyglucose uptake in the PN60 WT and glut3+/− brains was measured 
using a modified Sokoloff method following the intraperitoneal administration of 0.5 
μCi/gm of 2-deoxy-D-[14C]-glucose tracer. The specific activity of glucose in circulation 
and cerebral cortical tissue over a predetermined optimal duration allowed for the derivation 
of cerebral glucose uptake as described previously (16, 17).
Brain lactate uptake
Cerebral lactate uptake in the PN60 WT and glut3+/− brains was assessed using a modified 
Oldendorf method (18) in which a mixture of L[14C(U)]-lactate and [3H]-water (0.1 μCi 
each) was injected via the left ventricle (LV) with collection of whole brains 15–20 seconds 
later. The ratio of 14C to 3H in brain tissue relative to the ratio of 14C to 3H in the injectate 
determined the amount of lactate lost to brain tissue on a single passage through brain 
microcirculation.
Immunohistochemical studies
Paraformaldehyde pre-fixed vibratome floating coronal brain sections were subjected to 
immunofluorescence staining using the rabbit anti-mouse GLUT3, guinea-pig anti-GLUT1 
or mouse anti-tubulin (1:500 dilution each) IgGs as primary antibodies with the fluorescent 
tag being FITC for GLUT1 and Texas Red for GLUT3 or tubulin. Slides with sections were 
examined under a Nikon E-600 fluorescence microscope (Nikon, Melville, NY) equipped 
with a cooled charged-coupled device (CCD) camera as previously described (11, 13). 
Neuronal nitric oxide synthase enzyme immunoreactivity was assessed by the primary rabbit 
anti-nNOS antibody (1:100 dilution) (BD Biosciences, San Jose, CA), biotinylated-
peroxidase-DAB reaction and viewed under the light microscope and cells counted by the 
NIH image analysis system (10, 13).
Neuroligin-3 mRNA studies
Total RNA was isolated from snap frozen dissected hippocampi (RNeasy lipid tissue mini-
kit, Qiagen, Valencia, CA) (19, 20). Real-time PCR primers used amplified a 75 bp isoform 
specific DNA fragment (forward:5′-ggagctggcagcattacagtt-3′, reverse:5′-
aggcgaagtgtgtcatgtg-3′) of the mouse neuroligin-3 sequence (GenBank no. NM_172932). 
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Taqman probe was the intervening sequence (5′-ccactcaccatgaatgtgaggccg-3′), which was 
synthesized and labeled with fluorescent dyes, 6-carboxyfluorescein (FAM) on the 5′ end 
and N,N,N,N-tetramethyl-6-carboxyrhodamine (TAMRA) on the 3′ end (Applied 
Biosystems, Foster City, CA). Quantitative real-time PCR (q-PCR) was performed in 
triplicate with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) serving as the internal 
control on the StepOnePlus™ Real-Time PCR system (Applied Biosystems, Foster City, 
CA). The amplification conditions consisted of initial 12-min activation at 95°C followed by 
40 cycles of denaturation at 95°C for 30s, annealing at 58°C for 30s, and extension at 72°C 
for 30s. Relative quantification of the PCR amplification products was performed using the 
comparative critical threshold (CT) method as previously described (19, 20).
Continuous video-EEG monitoring
Following isoflurane anesthesia administration, the two leads of the EEG transmitter were 
operatively implanted on the dura through two drilled bilateral burr holes in the skull on 
each side of the fronto-parietal cranium, 1.4 mm in diameter, 3 mm posterior and 3 mm 
lateral to the Bregma. After surgery, the mice ranging in age from 4–6 to 8–12 months of 
age were transferred to the cage which was placed on top of the telemetry receiving platform 
(Data Sciences International, Arden Hills, MN) and continuous EEG monitoring was 
performed for 24–48 hours after three hours of recovery. Stellate software (Montreal, 
Quebec, Canada) was used to capture the data which was then manually reviewed offline for 
epileptiform events. Analysis was done based on amplitude, frequency and time with EEG 
evidence of seizures (21).
Neurobehavioral Studies
Different sets of naïve 4–6 month old mice were employed for SHIRPA, T-maze, Morris 
water maze and fear conditioning tests each. Another set of naïve mice of the same age was 
subjected to open field followed by the roto-rod testing after a minimal interval of 10 days 
between the two tests. This same set of mice underwent the radial arm maze test at 7–8 
months of age. A different set of naïve mice at postnatal age of 7 days was subjected to the 
ultrasonic vocalization (USV) test and a separate set of 40 day old mice was engaged for 
social behavior testing and subsequently examined for stereotypic behaviors at 50 days of 
age. The same set along with a naïve set of mice at 60 days of age underwent the olfactory 
sensitivity testing.
SHIRPA primary screen
A primary observational screen based on a modified Irwin (22) profile was performed as 
described previously (23). Behavioral and functional profile screen included quantitative 
scoring to detect defects in gait or posture, motor control and coordination, changes in 
excitability and aggression, autonomic function such as salivation, lacrimation, piloerection, 
defecation and muscle tone.
Accelerating rotarod
Motor coordination was assessed with the accelerating rotarod (TSE-Systems, RotoRod 
3375-5, Hamburg, Germany) as described previously (24) with slight modification. Each 
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trial started either at a constant forward rotational speed of 5 rpm or at an accelerating speed 
beginning at 5 rpm up to 60 rpm. Trials were completed after experimental subjects fell of 
the rod or 300 s at a maximum speed of 60 rpm had elapsed, whichever came first. One 
daily trial was given for 4 consecutive days. Primary measure of interest was latency to fall.
Open Field Test
Spontaneous behavioral activity was recorded in an activity chamber (Med-Associates Inc, 
ENV-520, St. Albans, Vermont) as described previously (25). Exploratory activity was 
measured in a square Plexiglas enclosure for 20 min. Movement within the open field area 
was recorded by the computerized Med Associates Activity Monitor. Measured parameters 
included distance traveled, ratio of center distance traveled to total distance traveled, 
average velocity, ambulatory time, stereotypic behavior time, resting time and vertical time.
Sociability and social recognition
The social testing apparatus was a rectangular, three-chambered box with dimensions of 
each chamber being 16 in. in length × 9 in. in width × 9.25 in. in height. Dividing walls were 
made of clear Plexiglas containing small circular openings (3 inches in diameter) allowing 
access into each chamber. The procedure (Crawley social approach task) (26) involved 3 
phases: habituation, tests of sociability and social recognition. The test mouse was first 
placed in the middle compartment and allowed to explore all 3 chambers for 10 min 
(apparatus did not contain any wire cages during habituation). After habituation, an 
unfamiliar mouse (stimulus mouse; age- and sex-matched to test mouse) was placed into one 
of the side compartments (constrained by a round wire cage that permitted nose contact 
between the bars but prevented extensive physical contact; stimulus mice were habituated to 
small wire cages for 5–10 minutes each for two days before testing), while the opposite side 
compartment only contained an empty wire cage. For evaluation of sociability, the test 
mouse was returned to the apparatus for 10 min. Active exploration (approach, sniffing, 
rearing) of the conspecific and the empty wire cage by the test mouse was recorded and 
scored offline. For the social recognition test, one side compartment of the apparatus 
contained a now familiar mouse (from the previous sociability phase), the other side an 
unfamiliar, novel mouse (both constrained by wire cages). Active exploration of familiar 
and novel unfamiliar mouse by the test mouse during the 10 min period was recorded for 
offline analysis and scored by an observer blinded to genotype.
Olfactory sensitivity test procedure
Two days prior to testing, an unfamiliar high carbohydrate containing food item (Froot loop) 
was placed in the home cages of the subject mice to ensure palatability. On the day of the 
test, each mouse was placed in a Plexiglas box (46 cm in length × 24 cm in width × 20 cm in 
height) containing 3 cm depth of bedding and allowed to explore for five minutes. The 
mouse was removed from the Plexiglas box and one Froot loop was buried in the bedding of 
the empty box. The mouse was returned to the box and allotted 15 min to locate the buried 
Froot loop. All activities were videotaped for offline analysis and the latency to find and 
consume the Froot loop was assessed (26).
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Ultrasonic vocalization (USV) tests
Quantification of USVs at a frequency of 70 KHz was carried out at PN7 as described 
previously (27). Pups were removed from the breeding cages (contained dam and offspring 
in a temperature of 24–25°C) in groups of four and placed individually into glass containers 
(4″ × 3″ × 2.5″ in a temperature of 22–23°C) that were housed in sound attenuation 
chambers. A four-channel Noldus UltraVox system (Noldus Information Technology Inc, 
Leesburg, Virginia) was used to record ultrasonic emissions generated by each animal. 
Immediately after a six minute recording period, a tail biopsy was obtained from each 
animal to permit genotyping (13).
T maze acquisition and reversal learning
T maze test was performed as described previously (28). Briefly, mice were initially food-
deprived until they had reached 85% of their ad libitum feeding body weight, habituated to 
the T-maze and shaped to consume 20 mg chow pellets (Test Diet Omnitreat Tab, 20 mg, 
Richmond, Indiana). Ten training trials per day were then initiated. For each mouse, one arm 
was designated as the correct arm that contained a food pellet during training trials (right 
and left side were counter balanced for both genotypes). At the beginning of each test 
session, mice were placed in the start box at the bottom of the T-maze stem. The start box 
door was opened, and the mice were given a choice of entering either arm. Upon making the 
correct choice, mice were given time to consume the food pellet before returning to the start 
box for the next trial. For each successive trial, the reward pellet was always placed in the 
same arm. Latency to enter an arm, number of errors, and number of days to criterion (80% 
correct responses on 3 consecutive days) was recorded by a human observer blind to 
genotype. Each mouse that met criterion for acquisition (66% of glut3+/− and 64% of WT) 
was subjected to reversal learning, during which the reinforcer location was switched to the 
opposite arm. Ten trials per day were administered for reversal learning, using the same 
methods and criterion.
Stereotypic behavior
Stereotypic behavior was assessed as described previously (29, 30). Mice (~50 days of age) 
were placed individually into a round Plexiglas cylinder (12 in. tall and 8 in. in diameter) 
and allowed to explore freely. Twenty-minute video recordings were made for each subject. 
Stereotypic behaviors including rotation, rears, sniffing, grooming and exploratory activity 
were subsequently scored by a human observer blinded to genotype.
Morris Water Maze Test
The hidden version of the Morris water maze (31) was performed to assess spatial learning. 
The task was carried out as described previously (32) with slight modification. Mice were 
initially trained to find an escape platform that was located in a constant location of the pool 
1 cm below the water surface (pool diameter: 1 m; platform diameter: 12 cm; water 
temperature: 24°C). Animals were released into the pool from alternating starting positions. 
Training trials terminated when the animal remained on the platform for 1 s or 60 s had 
elapsed, whichever came first. Mice were allowed to remain on the platform for a 5 s post-
trial interval. Two training trials per day were performed. The accuracy with which animals 
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had learned the platform location was monitored with a single probe trial given after 
completion of training (probe trial duration: 60 s; platform was removed from the pool 
during probe trials). Visible platform training was given after the hidden version of the 
Morris water maze had been completed. Tracking information was processed by the HVS 
Water maze software package (HVS Image, Buckingham, United Kingdom). Primary 
measures of interest were escape latency for training trials and quadrant occupancy, target 
crossings and proximity for probe trials.
Radial Arm Maze
Spatial working memory was assessed using a win-shift version of the 8-arm radial maze 
(Lafayette Instrument Co, Lafayette, Indiana) as described previously (33). Mice were 
initially food-restricted (until they had reached 85% of their free-feeding body weight), 
shaped to consume 20 mg chow pellets (Noyes Precision Pellets, 20mg, P.J. Noyes 
Company, Inc, Lancaster, New Hampshire) and habituated to the maze (three 5 min sessions 
during which all arms were baited and accessible). Mice were given 1 daily session 
(consisting of 2 phases separated by 3 h) for 15 consecutive days on the radial arm maze. 
During phase A, animals were allowed to retrieve a 20 mg food pellet from 4 pseudo-
randomly chosen arms of the 8-arm maze, while access to the remaining 4 arms was 
blocked. Phase A terminated after animals had retrieved all 4 food pellets or 5 min had 
elapsed, whichever came first. Mice were returned to the maze for phase B after a 3 h 
interval. During phase B, all arms were accessible but only the 4 previously blocked arms 
were baited. The baiting pattern of the maze was pseudo-random (no more than three 
adjacent arms were baited during either phase) and changed every session, as was the order 
in which the mice were run. Phase B terminated the same way as phase A after animals had 
retrieved all four food pellets or 5 min had elapsed, whichever came first. Three consecutive 
training sessions consisting of phases A and B were combined into one block session and a 
total of 5 block sessions were conducted. Phase B entries into arms that were baited only 
during phase A were scored as across-phase errors. Repeated entries into the same arm were 
scored as within-phase errors. In addition, total arm entries were scored and latencies to 
complete phase B recorded. As glut3+/− mice showed a reduced number of total arm entries, 
errors (across-phase errors, within-phase errors) were normalized to total arm entries. A 
minimum of 2 total arm entries during phase A was required for subjects to qualify for phase 
B error analysis.
Contextual Fear Conditioning
Mice were conditioned to the training context with 3×2 s, 0.75 mA shocks (placement to 
shock interval: 2 min; shocks were spaced by 1 min; training trial duration: 5 min) as 
described previously (34). Context fear was assessed after 24 h (5 min session). Freezing 
and activity levels were recorded and measured by an automated system (Med-Associates 
Inc, St. Albans, Vermont).
Statistical Analyses
All data are presented as mean±SEM. T-test or Fisher’s Exact test was employed for protein 
expression, metabolic and seizure studies. T-test with Bonferroni’s correction when 
indicated or two-way repeated-measures ANOVA was used for neurobehavioral studies. At 
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a significance level of p < 0.05 for two-way repeated measures ANOVA, Tukey’s posthoc 
analysis was subsequently performed.
Results
Brain glucose and monocarboxylate transporters
The developmental profile of brain GLUT3 protein consisted of an age related increase from 
postnatal day (PN)1 and PN7 to that of PN14, 21 and 60 in both wild type (WT) and 
glut3+/− mice. The glut3+/− mice demonstrated lower GLUT3 protein concentrations 
throughout development (figure 1.I.a & b). Examination of intracellular localized neuronal 
GLUT8 (10) revealed no inter-genotype differences except at PN14 when glut3+/− mice 
exhibited higher concentrations (figure 1.I.a & c). The microvascular and glial GLUT1 (8) 
revealed an age-dependent increase in brain GLUT1 protein concentrations at PN21 and 60 
in both WT and glut3+/− mice, however contrary to GLUT3, a higher concentration of 
GLUT1 was observed in glut3+/− mice versus WT at these two ages (figure 1.I.a & d). 
Investigation of the monocarboxylate transporters demonstrated no change in brain 
(microvascular and glial) MCT1 (35) through development and between the genotypes 
(figure 1.I.a & e). In contrast, neuronal MCT2 (35) increased with development at PN60 in 
WT mice, with the glut3+/− mice demonstrating an earlier increase from PN14 through 
PN60 when compared to the age-matched WT mice (figure 1.I.a & f).
Brain 2-deoxyglucose and lactate uptake
These age-related changes in other GLUT and MCT isoforms led to a lower trend in glut3+/− 
versus WT in total brain 14C-2-deoxy-glucose uptake (WT = 1113±187 vs. glut3+/− = 
887±91 μmol/mg/min; n = 12–13 each). In contrast, brain lactate uptake increased in 
glut3+/− versus WT mice (WT = 288±9 vs. glut3+/− = 324±14 μmol/mg/min, n = 6 each, 
unpaired t-test p < 0.05). Gross body weights (WT = 32.8±5 vs. glut3+/− = 34±4 gm, n = 20 
each), and brain weights (WT = 0.33±0.02 vs. glut3+/− = 0.32±0.03 gm, n = 20 each) were 
no different between the PN60 glut3+/− and WT mice.
Glucose transporter and other marker proteins localization and expression
Brain histology was no different between the PN60 glut3+/− and WT mice. Neuronal nitric 
oxide synthase immunoreactivity, a surrogate marker for neuronal oxidative injury due to 
glucose deprivation, was no different between the two genotypes (n = 10/genotype, data not 
shown). No ectopic expression of GLUT1 in neurons despite GLUT3 deficient neurons was 
noted in any brain structures; instead GLUT1 immunolocalization was limited to 
microvasculature in brain sections of glut3+/− and WT (figure 1.II.a & b) mice. Tubulin 
immunoreactivity, a surrogate for intact cellular processes, was preserved (figure 1.II.c & d). 
In contrast, the expression of hippocampus neuroligin-3, a marker of mature functional 
GABA and glutaminergic synapses, was slightly lower in glut3+/− versus WT mice (WT = 
1.01±0.03 vs. glut3+/− = 0.93±0.02* arbitrary units, n = 11 to 12 each, unpaired t-test, *p < 
0.05).
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Continuous Video-Electroencephalographic monitoring
Functional assessment by continuous electroencephalographic (EEG) telemetry recording 
demonstrated seizure activity in some of the glut3+/− versus age matched WT mice (WT = 
0.034±0.017 and glut3+/− = 0.55±0.24 average seizure frequency/hr, unpaired t-test, *p < 
0.05) with a trend towards increased spike activity in the former versus the latter (WT = 
6.90±3.97 and glut3+/− = 19.35±7.10 average spike frequency/hr) (figure 2.I. d & e). The 
incidence of EEG seizures was also higher in glut3+/− versus WT mice (Fisher Exact test, p 
< 0.05) as was the increasing trend in spike activity (figure 2.I. a–c). As described 
previously in sham rats, idiopathic seizures were observed in C57BL/6 WT mice as well, 
albeit at a 16-fold lower rate than the glut3+/− mice, reinforcing the importance of 
simultaneous systematic monitoring of appropriate strain-specific controls (36). Rarely 
glut3+/− mice were observed to demonstrate tonic posturing (figure 2.I. a) or a behavioral 
arrest but most glut3+/− mice were asymptomatic when seizures were observed on EEG 
(figure 2.I. b) unlike the EEG tracing seen in most of the WT mice (figure 2.I. c). All 
behavioral and cognitive analyses were performed in mice lacking spontaneous seizures, 
which constituted most of them.
Neurobehavior testing: SHIRPA primary screen, motor skills and locomotor activity
Quantitative measures of SHIRPA primary screen (23) are presented in table 1. No 
differences were initially observed between WT controls (n = 27 mice) and glut3+/− mice (n 
= 28 mice) The latency to fall in the rotorod test (supplemental figure 1), the total distance 
traveled, the ratio of center distance to total distance traveled, average velocity, time spent in 
center versus periphery and time spent in different activities in the open field test 
(supplemental figure 2) and the path length and speed of travel in the water maze swim test 
(supplemental figure 3) were no different between the two mouse genotypes.
Sociability and Social Recognition
Impaired social behaviors, including lack of social interest, are an important feature of ASD. 
Accordingly, social interaction of glut3+/− mice and WT controls was examined using a 
social choice paradigm (26). After a brief habituation phase, mice were allowed to freely 
explore a 3-compartment apparatus. One side compartment contained a stimulus mouse 
constrained to this location by a round wire cage, while the other side compartment 
contained an empty wire cage. Consistent with previous reports (26), WT mice spent more 
time actively exploring the cage containing the conspecific than the empty cage; this pattern 
was reversed in glut3+/− mice which spent more time exploring the empty cage than the cage 
containing the stimulus mouse (figure 2.II. a). Moreover, glut3+/− mice spent significantly 
less time exploring the conspecific than WT controls (figure 2.II. a) and therefore lacked 
normal levels of social exploration. Further, these glut3+/− mice when subjected to a social 
recognition test spent less time with the unfamiliar than the familiar mouse, supporting 
diminished aptitude for social novelty (figure 2.II. b). Sex-specific analysis revealed no 
differences in either sociability or social recognition. These data demonstrate that 
heterozygous glut3 deletion results in abnormal social interaction, including diminished 
social approach behavior and a lack of preference for social novelty. Other factors such as 
locomotor activity that could influence the transition between chambers (supplemental 
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figure 4. a–b) and olfactory sensitivity that could affect sociability (supplemental figure 4. c) 
were no different between the two mouse genotypes.
Communication deficits by ultrasonic vocalization (USV) tests
Human subjects with ASD frequently show language and communication deficits. It is 
unclear to what extent vocalizations in mice serve communicative functions and how 
impairments in mice relate to autism-associated communication deficits. Nevertheless, at 
least limited forms of vocal communication appear to exist in mice: Upon separation from 
the dam, mouse pups emit vocalizations in the ultrasonic range that induce retrieval by the 
dam (27). To assess whether GLUT3 deficiency impacts pup vocalizations, these separation 
calls were quantified in glut3+/− mice and WT controls. Glut3+/− mice in the absence of any 
thermal regulatory differences showed a significantly lower duration (figure 2.II. c) and 
significantly lower rates of vocalizations (figure 2.II. d) than WT controls, demonstrating 
that GLUT3 deficiency impairs vocalizations in mice.
Cognitive flexibility by T maze acquisition and reversal learning
The range of behavioral repertoires in subjects with ASD is often restricted and not flexibly 
applied to environmental demands. We examined cognitive flexibility in glut3+/− mice and 
WT controls using a T-maze task (28). During the acquisition phase, food-deprived mice 
were trained to retrieve a food reward from one constantly baited arm of a T-maze, while the 
other arm remained unbaited. After the animal had reached a performance criterion (visiting 
the correct arm in at least 80% of cases for 3 consecutive days; 65% of mice), the 
contingency of the task was changed such that the food reward was located exclusively in 
the previously unbaited arm (reversal learning). While WT mice and glut3+/− mutants 
learned to correctly choose the baited arm at comparable rates during acquisition (figure 3. 
a), reversal learning was significantly slower in glut3+/− mutant mice (figure 3. a), 
suggesting impaired cognitive flexibility in glut3+/− mutant mice.
Stereotypic behaviors
Repetitive behaviors in subjects with ASD may manifest as motor stereotypies, such as hand 
flapping, body rocking or head rolling. Stereotypical movements were quantified in freely 
behaving glut3+/− mice and WT controls (29, 30). While there was no significant difference 
between genotypes in rearing, sniffing, exploring and grooming (supplemental figure 5. a–
e), glut3+/− mice spent substantially more time in rotational movements than WT controls 
(figure 3. b & c), demonstrating GLUT3 deficiency resulted in abnormal motor stereotypies. 
Interestingly, excessive motor stereotypies in glut3+/− mice were not seen in the social 
interaction tasks (data not shown) and open field test (data not shown), suggesting that these 
behaviors may be present in certain environmental conditions only (e.g. cylindric 
environment for the study of stereotypical behaviors as opposed to larger square-shaped 
environments in the open field and social interaction task). Accordingly, it can be ruled out 
that repetitive rotational behaviors may have confounded the assessment of social behaviors 
in our studies.
Zhao et al. Page 10
Mol Psychiatry. Author manuscript; available in PMC 2014 October 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Spatial cognition by Morris water maze test
Mental retardation and specific learning disabilities constitute important co-morbidities of 
ASD. To examine whether GLUT3 deficiency adversely affects spatial cognition, mutant 
mice and WT controls were trained on the hidden version of the Morris water maze (31, 32). 
Analysis of escape latencies showed a non-significant trend towards higher escape latencies 
in glut3+/− mice (figure 4. d). As escape latencies generally are a poor indicator of spatial 
learning (37), we tested the accuracy with which the platform location was learned by 
delivering a probe trial (during which the platform was removed from the pool) after 
completion of acquisition training. Probe trial data indicated that WT mice had a trend 
towards higher target quadrant occupancy scores (figure 4. a), searched closer to the 
previous platform location (figure 4. c) and crossed the exact target position more frequently 
(figure 4. b) than glut3+/− mice. Total path length covered and swim speed during the probe 
trial did not differ between genotypes (supplemental figure 3. a-b). Moreover, training in the 
visible version of the Morris water maze revealed normal escape latencies in glut3+/− mice 
(figure 4. d). These data suggest that perceptive, motivational and motor skills were normal 
in glut3 mutant mice and that the observed deficit in the hidden version of the Morris water 
maze reflects impaired spatial cognition in glut3+/− mice.
Spatial working memory by radial arm maze test
Next, we tested spatial working memory in glut3+/− mice and WT controls in a delayed-non-
match-to-place version of the 8-arm radial maze (33). During phase A of the task, food-
deprived mice were allowed to retrieve reward pellets from four pseudo-randomly baited 
arms, while access to the other four arms was blocked. After a 3 h delay, mice were returned 
to the maze and were allowed to enter any of the 8 arms. However, only the previously not 
accessible arms were baited during this phase of the task (phase B). Mice can commit 
different types of errors in this task: they can fail to visit a baited arm (omission error), visit 
an arm that was only baited during phase A (across-phase error) or repeatedly enter an arm 
during phase B (within-phase error). Glut3+/− mice made significantly more omission errors 
than WT controls (two-way repeated-measures ANOVA with genotype as between-subjects 
factor and session as within-subjects factor, effect of genotype: F (1, 28) = 14.757, p < 
0.001, data not shown) and showed a lower number of total arm entries (supplemental figure 
6. a). Glut3+/− mice committed more across-phase errors relative to total arm entries than 
WT mice (figure 4. e), while within-phase errors/total arm entries were not affected in glut3 
mutants (two-way repeated-measures ANOVA with genotype as between-subjects factor 
and session as within-subjects factor, effect of genotype: F (1, 28) = 0.114, p = 0.738, data 
not shown). These observations suggest that GLUT3 deficiency led to a cognitive 
impairment suggestive of hippocampal dysfunction, while also affecting overall arm entries.
Altogether, the data show that GLUT3 deficiency caused cognitive deficits in two 
hippocampus-dependent tasks, namely the water and radial arm maze tasks.
Emotional working memory by contextual fear conditioning test
No deficits in one other emotion based measure of context learning in a fear conditioned 
task were observed (supplemental figure 7). The acquisition of contextual conditioning can 
be hippocampus-dependent. However, animals can use non-hippocampal strategies to 
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recognize the training context (38). Thus, no difference between glut3+/− and WT mice 
supports non-hippocampal mediated learning and working memory to be intact.
Discussion
We have characterized the neurodevelopmental phenotype of glut3 heterozygous null mice. 
These mice demonstrate compensatory brain metabolic changes, increased 
electroencephalographic seizure activity, abnormal spatial learning and working memory, 
perturbed cognitive flexibility with intact gross motor ability, altered social behavior, 
reduced vocalization with low frequency stereotypies.
Our observations support an association between the decline in neuronal GLUT3 and an 
increase in brain GLUT1 and MCT2 concentrations during the suckling and early post-
suckling phases of development. Since GLUT1 mediates glucose transport across the blood 
brain barrier and into glial cells, compensatory increase in GLUT1 noted in glut3+/− mice 
was associated with none to minimal diminution in total brain 2-deoxy-glucose uptake. This 
finding may reflect the net effect of the increase in endothelial and glial GLUT1 but 
decrease in neuronal GLUT3 mediated glucose uptake. The compensatory increase in 
neuronal MCT2 but not endothelial/glial MCT1 paralleled the enhanced brain lactate uptake. 
Thus, neuronal glucose deficiency was compensated by increased lactate supply suggesting 
an exclusive increase in neuronal lactate uptake.
To ascertain this phenomenon isolation of specific brain cell types is required. However, in-
vitro isolation and culturing of neurons induces GLUT1 (39, 40), while culturing of 
astrocytes induces GLUT3 expression (41) thereby no longer reflecting the in-vivo state. 
Accurate in-vivo ascertainment of neuronal glucose uptake separate from that of glial cells 
without disrupting the inter-cellular communications is difficult to accomplish. In keeping 
with these experimental barriers, previous investigations employing isolated and cultured 
astrocytes from newborn glut3+/− and WT mice failed to detect differences in either 2-
deoxyglucose uptake or lactate release into the culture medium (42). If these in-vitro results 
are taken at face value, with no information regarding cellular GLUT1, GLUT3, MCT1 and 
MCT2 expression, the lack of any inter-genotype difference supports no protective role for 
the astrocyte in the presence of neuronal glucose deficiency. This observation goes against 
the “astrocyte-neuron lactate shuttle” concept put forth by other investigator groups (43). In 
contrast, our present in-vivo observations support a compensatory increase in blood-brain 
barrier GLUT1 mediated 2-deoxy-glucose transport from the circulation into the brain 
interstitium/glial cells, thereby minimizing the decrease in glut3+/− brain glucose uptake. 
Since neuronal glut3+/− deficiency sets the stage for a neuronal energy deficit, an increased 
neuronal MCT2 dependent lactate uptake based on enhanced blood-brain barrier transfer of 
lactate is plausible. Despite these metabolic compensations, disturbances in neuronal 
function were observed. These disturbances consisted of electroencephalographic seizure 
activity and certain neurobehavioral abnormalities.
In contrast, glut1 mutation created by anti-sense technology has serious structural effects 
causing major brain malformations in zebra fish and mouse (44, 45). On the other hand, 
glut1 haplo-deficient mice demonstrated a normal body size but a small sized brain, 
Zhao et al. Page 12
Mol Psychiatry. Author manuscript; available in PMC 2014 October 24.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
diminished brain glucose uptake on positron emission tomography, with abnormal motor 
activity and EEG seizures (46). However, neurobehavior related to learning, memory or 
anxiety was not assessed. Paralleling findings in mice, the autosomal dominant GLUT1 
deficiency syndrome due to Glut1 mutations in human infants is noteworthy for 
developmental delay, a spastic ataxic gait and seizure disorder (47–49). This aberrant 
neurodevelopment is partially ameliorated by a ketogenic diet (50). GLUT1 deficiency has 
the propensity to globally affect both neurons and glia by curbing glucose entry across the 
blood-brain barrier (49). GLUT1 expressing astroglia that are thought to serve as a local 
supplier of an alternate substrate, i.e. lactate, to glucose deficient neurons may also be 
negatively affected (7, 43). Thus GLUT1 deficiency that leads to low cerebrospinal fluid 
glucose and lactate concentrations in the presence of normal plasma glucose concentrations 
reflects diminished glucose transport across the blood-brain barrier (47, 49). GLUT3 
deficiency on the other hand selectively affects the glucose supply to GLUT3 expressing 
neurons compromising their energy metabolism.
Although GLUT4 and GLUT8 are also expressed in neurons within certain brain structures 
(10, 11), neurobehavior has not been examined in glut4 null homozygous or heterozygous 
mutant mice (51, 52). In contrast, glut8 null homozygous mutation caused minimal increase 
in hippocampus volume (53), with hyperactivity, reduced risk assessment and increased 
emotional reactivity to a novel environment (54). This presentation consistent with an 
anxiety disorder was not replicated in glut3+/− mice previously (42). Instead we presently 
observed a phenotypic presentation in glut3+/− mice that resembled clinical features of ASD 
in humans.
ASDs affect an estimated 5 to 6 per 1000 children at 3–10 years of age. Diagnostic screens 
may detect this disorder as early as 12 to 36 months of age. The presenting features consist 
of deficiencies in sociability, communication difficulties with problems in learning and 
utilizing language appropriately, difficulties in executive functioning, and repetitive 
behaviors although the individuals appear physically normal and exhibit good muscle 
control (55). Akin to this clinical presentation the glut3 haplo-insufficient mice 
demonstrated stereotypic behaviors consisting of rotational activity at low frequency and 
expressed perturbed vocalizations and social behaviors.
The stereotypic behavior observed was seen in more restrictive environments and did not 
affect grooming behavior. In contrast, another in-bred mouse strain with features relevant to 
autism (BTBR T+tf/J) demonstrated high levels of repetitive self-grooming (29). The 
reduction in USVs may reflect the early signs of disturbed communication in ASD. Maternal 
and sibling separation lends to social isolation resulting in vocalizations in response to 
maternal potentiation (56). C57BL/6 mice in general demonstrate a low rate of vocalization 
reflective of a higher maternal responsiveness (56). Nevertheless, in this strain we observed 
a genotype specific difference in vocalization. Previously, hypothermia incurred on 
separation of pups from the maternal nest (30°C to 19°C) stimulated vocalization 
abnormalities (57). In our present investigation, we avoided hypothermia and have 
previously observed no difference in body temperature regulation between the glut3+/− and 
WT mice (58). Others have examined the role of larger lung capacity or abdominal pressure 
induced increased venous return on perturbing postnatal USVs in mice (56). Our present 
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investigations examined WT age-matched littermates and glut3+/− mice under similar 
conditions and detected a reduction in USVs reflective of a communication disability in the 
mutant mice. This reduction in USVs has been observed in other mutant mice that have 
neurodevelopmental disorders related to abnormal synapses, examples include the Reeler 
mice, neuroligin-3 and neuroligin-4 null mice (56, 59, 60). A reduction in USVs is also 
observed in Foxp2 mutant mice, this gene mutation being responsible for human verbal 
dyspraxia, dysphagia and other severe language and speech disorders (56). These previous 
observations are of particular significance, since GLUT3 is localized to synapses (7, 9, 12).
In contrast to our findings in glut3+/− mice, the Mecp2 mutant mouse model of Rett’s 
syndrome demonstrated a dramatic increase in USVs perhaps related to associated 
alterations of respiratory function and cholinergic deficits (56). Similarly, in another inbred 
strain of mice, BTBR T+tf/J, several traits relevant to autism were detected including 
emission of a higher number albeit restricted categories of calls (27). In the human disorder 
of ASD the difficulty in communication spans a spectrum ranging from no response to 
external social stimuli to inappropriate outbursts (1, 61). Earlier during infancy, the normal 
cooing and babbling may not exist or is replaced by humming or grunting (1, 61). The 
impaired social behavior detected in glut3+/− mice is similar to that reported in the BTBR T
+tf/J mouse relevant to autism (26, 27).
Other problems that may accompany the clinical picture of ASD are sensory problems, 
mental retardation and specific learning disabilities. We observed impaired working memory 
and spatial cognition that relied on environmental cues and cognitive inflexibility in glut3 
haplo-insufficient mice. These features were previously either not examined at all, 
investigated with incomplete testing (e.g. lack of probe trial in the water maze test) or 
inadequate power to detect differences or were masked by a battery of neurobehavioral tests 
imposed in succession on the same set of glut3+/− mice (42). However, in our present 
investigation emotional working memory which may be non-hippocampus mediated (38) 
was not altered under fear contextual conditions.
One in four children with ASD develops seizures that may start during childhood or 
adolescence. While occasionally these seizures are clinically apparent, frequently sub-
clinical epileptiform activity can only be detected by overnight EEG monitoring. These EEG 
changes may contribute to abnormal neurobehavior and cognition which are diagnostic of 
ASD (55). Wide variations in prevalence rates of epileptiform activity in ASD patients have 
been reported. Typically, antiepileptic therapy is used in ASD patients with epilepsy, 
contributing towards some of the variability reported. Our glut3+/− mice demonstrated ~62% 
incidence of seizures akin to the higher end reported in human ASD. The glut3 mutant mice 
displayed a mixture of seizure phenotypes; some mice demonstrated overt tonic seizures 
while others had subtle clinical manifestations such as behavioral arrest or were 
asymptomatic, making detection difficult without extensive video-EEG recording. Recent 
neuro-imaging investigations demonstrate decreased brain glucose uptake and aberrant intra-
cortical connectivity in this disorder (4). Whether decreased brain glucose uptake and 
aberrant inter-neuronal connectivity form the cause or effect of ASD is unclear from such 
studies. Aberrant neuronal GLUT3 mediated glucose uptake as the common mechanistic 
denominator of ASD has never been explored previously.
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GLUT3 is mainly noted on neuronal processes that mediate inter-neuronal connectivity 
particularly in the cortical gray matter thereby ensuring adequate glucose supply at synapses 
that require high energy (7, 9, 12). Neuroligin-3 (NLGN3), an extra-cellular matrix protein 
that interacts with neurexin (NRXN) receptors in the synaptic cleft to mediate synaptic 
maturation and neurotransmission is dysfunctional in ASD (62, 63). Polymorphisms or 
mutations of NLGN3 that cause protein unfolding and aggregation in the endoplasmic 
reticulum are seen in ASD (64). Due to redundancy of neuroligins and neurexins, NLGN3 
mutant mice did not while NLGN4 mutant mice displayed apparent autism-like phenotype 
(59, 60). More recent evidence in human autism however demonstrates deletion of genes 
(NLGN3, NLGN4, NRXN1, PCDH10 and CNTN3) responsible for activity-regulated 
synaptic development mediating postnatal experience-dependent neural activity which in 
turn forms the basis for learning and memory (65). Our present glut3 heterozygous null mice 
show neurobehavioral features relevant to ASD, a diminution of the GLUT3 protein and a 
mild but significant decline in NLGN3 expression on inter-neuronal connecting processes. 
Our present novel observations set the stage for investigating the association of Glut3 
mutations or polymorphisms in similar human neuropsychiatric disorders with EEG seizures 
or EEG seizures that result in neurobehavioral consequences.
In conclusion, neuronal GLUT3 deficiency causes increased EEG seizures which may not be 
clinically detected, significant deficiencies in spatial learning and working memory reliant 
on environmental cues, cognitive inflexibility, stereotypic behaviors of low frequency and 
abnormal social behaviors and vocalizations, features not unlike those encountered in ASD. 
This novel observation lends credence to future investigations of dietary or pharmacological 
interventions targeted at potentially rescuing and/or reversing the progression of this 
devastating condition.
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Figure 1. I. Brain GLUT and MCT proteins
a. Western blots show GLUT3, GLUT8, GLUT1, MCT1 and MCT2 with respective 
vinculin protein bands in PN 1–60 WT and glut3+/− mice. b–f. Densitometric quantification 
as a percent of PN60 value is shown (n = 7/genotype) b. GLUT3, *p < 0.05 vs. age-matched 
WT, #p < 0.05 vs. PN1 glut3+/−, **p < 0.01 vs. PN1 WT, c. GLUT8, *p < 0.05 vs. PN7 
glut3+/−, #p < 0.05 vs PN14 WT, d. GLUT1, *p < 0.05 vs. age-matched WT, #p < 0.05 vs. 
PN1 WT, **p < 0.001 vs. PN1 glut3+/−, e. MCT1 and f. MCT2, *p < 0.05 vs. age-matched 
WT, **p < 0.01 vs PN1 WT, ***p < 0.001 vs PN1 glut3+/−. II. GLUT3 and GLUT1 
immunofluorescence a, b. Sub-fornical organ (SFO) with GLUT3 in neuronal processes (red; 
arrows), GLUT1 in microvessels (green; arrowhead) and DAPI nuclear staining (blue) in 
PN60 WT (n = 10) and glut3+/− (n = 10) brain sections. c–d. Tubulin in cellular processes 
(arrows) is observed in PN60 WT (n = 4) and glut3+/− (n = 4) cerebral cortical regions. Scale 
bar = 100μm.
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Figure 2. I. Extended video-EEG monitoring
a–c. Epileptiform activity accompanied by distinct behavioral phenotypes in glut3+/− mice is 
shown. a. Periodic seizures were seen with exploratory behavior that progressed into tonic 
extension of forelimb and tail (inset) followed by post-ictal depression (arrowhead). b. 
Prolonged recordings reveal distinct epileptiform activity with no clear motor component. 
The dashed lines encompass the segment of recording that corresponds to the behavior 
shown. The horizontal scale bar is 1 s for the tracings, and 4 cm for the insets. c. A 
representative baseline tracing consisting of alpha slow waves in WT mice is shown. d–e. 
EEG seizures (>6 s) (d) and spikes (<6 s) (e) per hour were quantified in WT (n = 19) and 
glut3+/− (n = 16) mice; unpaired t-test, *p<0.05. II. a–d. Glut3 deficiency led to impaired 
social interaction and reduced separation calls. a. WT mice (n = 18) spent significantly 
more time exploring a conspecific than an empty cage in a social choice paradigm (two-way 
repeated-measures ANOVA with genotype as between-subjects factor and compartment as 
within-subjects factor, genotype x compartment interaction: F (1, 40) = 30.312, p < 0.001; 
Tukey post-hoc analysis: WT-conspecific vs. WT-empty cage: ***p < 0.001). Glut3+/− mice 
(n = 24), in contrast, spent more time exploring the empty cage than they spent interacting 
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with the conspecific (**Tukey post-hoc analysis, p = 0.004). Moreover, glut3+/− mice spent 
significantly less time exploring the conspecific than WT controls (Tukey post-hoc analysis, 
***p < 0.001), and therefore lacked normal levels of social exploration. b. Glut3+/− mice 
failed to show preference for the novel mouse in a social recognition task (two-way 
repeated-measures ANOVA, genotype x compartment interaction: F (1, 40) = 45.41, p < 
0.001; Tukey post-hoc analyses: time spent exploring familiar mouse vs. novel mouse; WT: 
n = 18, ***p < 0.001; glut3+/−: n = 24, p = 0.106; time spent exploring unfamiliar mouse, 
WT vs. glut3+/−: ***p < 0.001). c–d. Ultrasonic vocalization (UV) testing (WT n = 38 mice, 
glut3+/− n = 35 mice) revealed diminished time spent in vocalizations (c) (two-way 
repeated-measures ANOVA with genotype as between-subjects factor and time point as 
within-subjects factor, effect of genotype: F(1, 71) = 4.88, *p = 0.03) and a diminished 
number of vocalizations/min (d) (two-way repeated-measures ANOVA with genotype as 
between-subjects factor and time point as within-subjects factor, effect of genotype: F(1, 71) 
= 7.558, **p = 0.008) in the glut3+/− vs. WT mice.
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Figure 3. Glut3+/− mice showed impaired cognitive flexibility and motor stereotypies
a. The time to reach criterion during acquisition training and reversal learning on a T-maze 
task is shown (WT: n = 9 mice, glut3+/−: n = 16 mice). No genotype difference was noted on 
acquisition (unpaired t-test, p = 0.518) but glut3+/− mice required more training than WT 
mice to reach criterion during the reversal phase (unpaired t-test, *p = 0.033). b–c. 
Stereotypic behavior tests: The number (b) (unpaired t-test, ***p < 0.001) and time (c) 
(unpaired t-test, ***p < 0.001) spent in rotations were increased in glut3+/− (n = 25) vs. WT 
(n = 22) mice.
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Figure 4. 
Glut3+/− mice showed impaired spatial learning in the Morris water maze and spatial 
working memory deficits in a win-shift version of the 8-arm radial maze. a–c. Quadrant 
occupancy, target crossings and proximity during the probe trial (WT: n = 13 mice; glut3+/−: 
n = 15 mice; pool quadrant: target (T), right (R), opposite (O) and left (L) quadrants). a. WT 
mice showed a trend towards higher target quadrant occupancy scores in comparison with 
mutant mice (two-way repeated-measures ANOVA, genotype x quadrant interaction: F (3, 
78) = 5.013, p = 0.003; Tukey post-hoc analysis, target quadrant occupancy in WT vs. 
mutant mice, p = 0.129). b. WT mice crossed the exact target position more frequently than 
glut3+/− mice (two-way repeated-measures ANOVA, genotype x quadrant interaction: F (3, 
78) = 3.116, p = 0.031; Tukey post-hoc analysis, target crossing in WT vs. mutant mice, *p 
= 0.013). c. Proximity to the target location was closer in WT mice than in mutant mice 
(two-way repeated-measures ANOVA, genotype x quadrant interaction: F (3, 78) = 5.065, p 
= 0.003; Tukey post-hoc analysis, proximity to target quadrant in WT vs. mutant mice, ***p 
= 0.001). d. Escape latency: A non-significant trend towards higher escape latencies was 
observed in glut3+/− mice (two-way repeated-measures ANOVA with genotype as between-
subjects factor and session as within-subjects factor, effect of genotype: F (1, 26) = 4.121, p 
= 0.053; data from 4–6 training sessions were averaged and are shown as one block session). 
In the visible platform task (VP), the escape latency of glut3+/− mice was similar to that of 
WT controls (unpaired t-test, p = 0.963). e. Radial arm maze: The number of across-phase 
errors normalized to total arm entries was higher in glut3+/− mice than WT controls (WT, n 
= 18 mice, glut3+/−, n = 12 mice, two-way repeated-measures ANOVA with genotype as 
between-subjects factor and session as within-subjects factor, effect of genotype: F (1, 28) = 
9.16, **p = 0.005).
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Table 1
SHIRPA primary screen score in glut3+/− mice (n = 28) and WT control mice (n = 27).
WT littermates glut3+/− p-value
Viewing jar
Body position 3.30±0.09 3.04±0.04 0.097
Spontaneous activity 1.82±0.14 1.89±0.09 0.595
Respiration rate 2.00±0.00 2.00±0.00 1.000
Tremor 0.67±0.13 0.68±0.10 0.826
Urination 0.07±0.05 0.07±0.05 0.993
Defecation 3.63±0.27 4.11±0.48 0.539
Arena
Transfer arousal 3.41±0.23 3.79±0.17 0.288
Locomotor activity 8.82±0.77 8.50±0.72 0.686
Palpebral closure 0.00±0.00 0.00±0.00 1.000
Piloerection 0.00±0.00 0.00±0.00 1.000
Startle response 0.96±0.04 1.00±0.00 0.819
Gait 0.00±0.00 0.00±0.00 1.000
Pelvic elevation 2.22±0.08 2.25±0.08 0.866
Tail elevation 1.41±0.10 1.32±0.09 0.589
Touch escape 2.04±0.08 2.07±0.10 0.839
Positional Passivity 1.00±0.00 0.96±0.04 0.825
Above Arena
Abnormal behavior 0.00±0.00 0.00±0.00 1.000
Visual placing 3.00±0.00 3.00±0.00 1.000
Grip strength 2.04±0.10 1.50±0.15 0.006
Body tone 1.00±0.00 1.00±0.00 1.000
Pinna reflex 1.00±0.00 1.00±0.00 1.000
Corneal reflex 1.00±0.00 1.00±0.00 1.000
Toe Pinch 2.52±0.15 2.75±0.13 0.316
Wire manoeuvre 0.11±0.08 0.04±0.04 0.806
Supine Restraint
Skin color 0.96±0.04 0.89±0.06 0.659
Heart rate 1.48±0.10 1.32±0.09 0.311
Limb tone 1.15±0.07 1.11±0.06 0.799
Abdominal tone 1.00±0.00 1.00±0.00 1.000
Lacrimation 0.00±0.00 0.00±0.00 1.000
Salivation 0.37±0.10 0.43±0.11 0.826
Provoked biting 0.67±0.09 0.68±0.09 0.946
Righting reflex 0.00±0.00 0.00±0.00 1.000
Contact righting reflex 1.00±0.00 1.00±0.00 1.000
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WT littermates glut3+/− p-value
Negative geotaxis 0.11±0.06 0.32±0.12 0.352
Fear 0.59±0.10 0.54±0.10 0.723
Irritability 0.41±0.10 0.36±0.09 0.755
Aggression 0.59±0.10 0.39±0.09 0.206
Vocalization 0.19±0.08 0.25±0.08 0.685
Unpaired t-test with Bonferroni’s correction, significance is achieved at a p < 0.001.
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